Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.77 |
| ▸ | ESR1 | P03372 | 2/20 | 0.55 |
| ▸ | PGR | P06401 | 2/20 | 0.55 |
| ▸ | HTR1A | P08908 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | AR | P10275 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | SELP | P16109 | 5/20 | 0.35 |
| ▸ | SELE | P16581 | 5/20 | 0.35 |
| ▸ | SELL | P14151 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 2/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10832586 | 0.88 | NOD2 (0.60) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL17299289 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyl Dipeptide SCHEMBL9770111 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL15263102 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL20516503 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL9231355 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL41814 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL19486934 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL20516502 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyl Dipeptide SCHEMBL41813 | 0.87 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2868 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025006896-A1 | LOW DOSE MURAMYL DIPEPTIDE ANALOGUE-CONTAINING COMPOSITIONS AND METHODS OF USING SAME FOR IMMUNOPROTECTION | NUTRIVERT INC. (US) | 2025-01-02 | — | — | WO | claimed |
| WO-2018195447-A1 | RECOMBINANT MVA-BASED HIV IMMUNOGENS AND USES THEREOF | GEOVAX LABS, INC. (US) | 2018-10-25 | — | — | WO | claimed |
| US-9982039-B2 | Mycobacterial antigen composition | THE SECRETARY OF STATE FOR HEALTH (GB) | 2018-05-29 | — | — | US | claimed |
| US-20160251415-A1 | Mycobacterial Antigen Composition | Secretary of State for Health and Social Care (GB) | 2016-09-01 | — | — | US | claimed |
| US-9339534-B2 | Mycobacterial antigen composition | THE SECRETARY OF STATE FOR HEALTH (GB) | 2016-05-17 | — | — | US | claimed |
| WO-2016008047-A1 | CYCLIC PEPTIDE VACCINATION FOR TREATMENT OF AMYLOID BETA-RELATED DISORDERS | CANGENE CORPORATION (CA) | 2016-01-21 | — | — | WO | claimed |
| US-9234040-B2 | Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells | BAYLOR RESEARCH INSTITUTE (US) | 2016-01-12 | — | — | US | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-8609107-B2 | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics | SANOFI PASTEUR LIMITED (CA) | 2013-12-17 | — | — | US | claimed |
| US-RE44399-E1 | One dose vaccination with Mycoplasma hyopneumoniae | ZOETIS LLC (US) | 2013-07-30 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| US-20080175854-A1 | Point mutations; antibodies; fusion proteins | GENOME THERAPEUTICS, INC. | 2008-07-24 | — | — | US | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-6846477-B2 | Preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. | PFIZER INC. (US) | 2005-01-25 | — | — | US | claimed |
| US-20050013823-A1 | One dose vaccination with Mycoplasma hyopneumoniae | PFIZER INC. | 2005-01-20 | — | — | US | claimed |
| US-20030109473-A1 | One dose vaccination with mycoplasma hyopneumoniae | PFIZER INC. | 2003-06-12 | — | — | US | claimed |
| US-5750114-A | GLYCOSYLATED GLYCOPROTEIN D POLYPEPTIDE | CHIRON CORPORATION (US) | 1998-05-12 | — | — | US | claimed |
| US-5747039-A | Recombinant herpes simplex gB-gD vaccine | CHIRON CORPORATION (US) | 1998-05-05 | — | — | US | claimed |
| US-5171568-A | Polypeptides are immunogenic, glycosylated and consists of glycoprotein B polypeptide and glycoprotein D or immunogenic fragments of glycoproteins | CHIRON CORPORATION (US) | 1992-12-15 | — | — | US | claimed |